Kersten Bartelt News Today

Med record data shows improvements in anxiety and depression in people taking the drugs for either diabetes or obesity.

People taking a popular type of drug for weight loss or to manage diabetes have a decreased likelihood of being newly diagnosed with depression or anxiety, according to an analysis of millions of people’s health records.

Weight loss drugs linked to lower likelihood of depression and anxiety diagnoses, according to a new study.

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglut...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglut...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglut...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglut...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglut...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglut...

Making breast cancer screenings an annual event could save women’s lives, new research suggests. In a study led by Epic Research, a health analytics firm based in Verona, Wisconsin, women who were screened for breast cancer on a yearly basis were shown to have a 17% lower risk of death by any cause compared to